Insider · CIK 0001889815
Indranil Dey
Files at BJDX (Bluejay Diagnostics, Inc.). First filing Dec 14, 2023, latest May 18, 2026.
In brief
Indranil Dey files SEC Form 4 as CEO, president, director and 10% owner at BJDX (Bluejay Diagnostics, Inc.). Since Dec 14, 2023, Indranil Dey has reported 2 open-market buys worth $27k and 0 open-market sells worth $0, the latest filed on May 18, 2026.
A track record needs three past buys with six months of prices behind them; Indranil Dey has 0, so none is measured yet.
The newest scored trade: bought $25k of BJDX on Mar 14, 2026, filed May 18, 2026, scored 55 (moderate). In the last 12 months: 1 buy worth $25k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BJDX: Bluejay Diagnostics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | Bluejay Diagnostics, Inc. | $25k 12,500 shares | first purchase | - | |
| 51Moderate | Bluejay Diagnostics, Inc. | $1,635 500 shares | +2% | 0% from low-83% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | BJDX Bluejay Diagnostics, Inc. | AGrant or award Common Stock | +28,000 | $0.00 | $0 | 40,522 | Aug 18, 2026 |
| Mar 14, 2026 | BJDX Bluejay Diagnostics, Inc. | POpen-market purchase Common Stock | +12,500 | $2.00 | $25k | 12,522 | May 18, 2026 |
| Dec 13, 2023 | BJDX Bluejay Diagnostics, Inc. | POpen-market purchase Common Stock | +500 | $3.27 | $1,635 | 28,526 | Dec 14, 2023 |
Questions about Indranil Dey
Answered from the filings on this page, as of the latest one.
Is Indranil Dey buying or selling?
In the last 12 months Indranil Dey reported 1 open-market buy worth $25k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $25k of BJDX on Mar 14, 2026. Grants, option exercises and tax withholding are not counted.
How did Indranil Dey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Indranil Dey has 0.
Where does Indranil Dey file Form 4?
Indranil Dey has filed Form 4 at BJDX (Bluejay Diagnostics, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.